July 28, 2021 10:22 AM EDTUpdated August 5, 03:55 PM

US sells Wu-Tang Clan album to cover Shkreli debt; OrbiMed backs GSK vets' Chinese startup

Amber Tong

Max Gelman

Senior Editor

Nicole DeFeudis

Editor

Martin Shkreli became a top target for ridicule and anger in the mid-2010s when he and his biotech Turing Pharmaceuticals raised the price of a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Biohaven stock sinks on three-month delay for neuro drug's FDA approval decision

Merck KGaA will continue to add a tariff surcharge for US customers

Hengrui, one of China's leading biotechs, anticipates $1.2B in proposed Hong Kong listing

FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer

Sanofi touts $20B investment in US over five years

GSK to pay $1.2B upfront to snag Boston Pharma’s mid-stage MASH hope